Dr. Jeffrey J. Caspar, MD

Dr. Caspar practices at UC Davis Medical Center in Sacramento, California, part of University of California Health.

Dr. Caspar's NPI, 1609850452, was assigned on December 5, 2005. Dr. Caspar graduated from UC Davis School of Medicine in 1992. Dr. Caspar holds California license G77585.

Dr. Caspar's primary practice is UC Davis Medical Center, at 2315 Stockton Boulevard, Sacramento, CA 95817 in Sacramento County. The practice phone is (916) 734-2011.

Dr. Caspar's primary practice is UC Davis Medical Center in Sacramento, California, part of University of California Health. The medical group on file is UC Davis Medical Group. Dmand AI also links Dr. Caspar to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Caspar practices, 3 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Caspar's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Caspar is board certified in ophthalmology by the American Board of Ophthalmology. Dr. Caspar is licensed in California.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, cold sores or genital herpes, dry eye, eyelid inflammation, glaucoma and glaucoma surgery among the conditions Dr. Caspar treats.

CMS data shows 1,940 Medicare services from Dr. Caspar across 15 procedure codes in 2024, for 876 Medicare patients. Medicare paid $285,545 for them.

CMS counts 876 Medicare patients who saw Dr. Caspar in 2024. The largest group is 75 to 84, with 432 patients. 75% of them have high cholesterol, and 67% have high blood pressure. 15% are also on Medicaid. Their average risk score is 1.11, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Caspar's median patient age at 73, with 57% women.

In 2024, Dr. Caspar wrote 1,282 Medicare Part D claims for 349 patients. 68% of them were for generic drugs. CMS names the drug for 1,233 of them, across 10 drugs with 11 or more claims each, at $49,676 in total drug cost. In 2023, CMS named 1,190 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Caspar for performance year 2024, reported as part of a group. Dr. Caspar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 543 procedures of cataract surgery by Dr. Caspar, more than 96% of the clinicians it reports for that procedure.

Dmand AI links 7 papers to Dr. Caspar, published from 2013 to 2020. The most frequent topics are Cataract Extraction, Keratomileusis, Laser In Situ and Lenses, Intraocular. Dr. Caspar has published most often in Cornea. Dr. Caspar's most frequent co-authors are Mark Joel Mannis, MD, Eric K. Chin, MD and Vahid Feiz, MD.

CMS Open Payments shows 207 general payments to Dr. Caspar from 7 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 43% of the total. Alcon Laboratories Inc paid the most, $75,580.

Dmand AI lists 3 awards for Dr. Caspar, most recently CMS Stage 1 EHR in 2012.

Dr. Caspar graduated from UC Davis School of Medicine in 1992. Dr. Caspar is a member of AAO.

Dr. Caspar is in network with 17 carriers, including Aetna, Blue Cross Blue Shield of Michigan and HCSC. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.